Skip to main content

Advertisement

Log in

Identification of steroid sensitive responders versus non-responders in the treatment of keloid disease

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Intralesional corticosteroid injection is a well-recognised treatment modality for keloid disease (KD). Approximately 50 % of KD cases are considered non-responders (or steroid resistant) with no consensus or indicators in detecting steroid-sensitive cases. In view of the undesirable side effects, uncertainty in timing and regularity of steroid treatment, we planned to identify responders and non-responders to target treatment more effectively. A scar injection proforma was developed capturing a detailed history focusing on symptoms and signs (redness, appearance, contour, texture, distortion and severity) associated with KD. The cause, site, number of keloid scars and scar recurrence were recorded as the lesions were injected on a monthly basis. A detailed description of response to steroid injection was documented and photographs were taken. Demographic data were collected on 65 patients (11 to 74 years with mean age 34.7 years, 60 % were females, 50 % were Caucasian). 77 % (n = 50) were classified as steroid responders and showed improvement in symptoms and signs within 3 months. There was a statistically significant correlation between patients with higher contour scores of KD prior to treatment (p = 0.013) and frequency of injections (p = 0.003). Thus, the odds of being a responder were greater for patients with more than one injection and with higher contour scores. This preliminary case series has provided early evidence in enabling identification of steroid responders versus non-responders within a 3-month period. Selection of KD non-responders to steroid treatment can avoid potentially painful injection, its subsequent side effects and unnecessary continuation of redundant therapy and follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Ardehali B, Nouraei SA, Van Dam H, Dex E, Wood S, Nduka C (2007) Objective assessment of keloid scars with three-dimensional imaging: quantifying response to intralesional steroid therapy. Plast Reconstr Surg 119:556–561

    Article  CAS  PubMed  Google Scholar 

  2. Asilian A, Darougheh A, Shariati F (2006) New combination of triamcinolone, 5-fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Dermatol Surg 32:907–915

    Article  CAS  PubMed  Google Scholar 

  3. Atiyeh BS (2007) Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices and emerging methods. Aesthet Plast Surg 31:468–492

    Article  Google Scholar 

  4. Bayat A, McGrouther D, Ferguson M (2003) Skin scarring. BMJ 326:88–92

    Article  CAS  PubMed  Google Scholar 

  5. Beausang E, Floyd H, Dunn KW, Orton CI, Ferguson MW (1998) A new quantitative scale for clinical scar assessment. Plast Reconstr Surg 102:1954–1961

    Article  CAS  PubMed  Google Scholar 

  6. Beranak JT (1997) Silicone gel sheeting for the management of hypertrophic and keloids scars: the mechanism of its action. Dermatol Surg 23:401–405

    Google Scholar 

  7. Berman B, Flores F (1999) Comparison of a silicone gel-filled cushion and silicone gel sheeting for the treatment of hypertrophic or keloid scars. Dermatol Surg 25:484–486

    Article  CAS  PubMed  Google Scholar 

  8. Boutli-Kasapidou F, Tsakiri A, Anagnostou E, Mourellou O (2005) Hypertrophic and keloidal scars: an approach to polytherapy. Int J Dermatol 44:324–327

    Article  PubMed  Google Scholar 

  9. Boyadjiev C, Popchristova E, Mazgalova J (1995) Histomorphologic changes in keloids treated with Kenacort. J Trauma 38:299–302

    Article  CAS  PubMed  Google Scholar 

  10. Brent B (1978) The role of pressure therapy in management of earlobe keloids: preliminary report of a controlled study. Ann Plast Sur 1:579–581

    Article  CAS  Google Scholar 

  11. Brown BC, McKenna SP, Siddhi K, McGrouther DA, Bayat A (2008) The hidden cost of skin scars: quality of life after skin scarring. J Plast Reconstr Aesthet Surg 61:1049–1058

    Article  CAS  PubMed  Google Scholar 

  12. Brown BC, McKenna SP, Solomon M, Wilburn J, McGrouther DA, Bayat A (2010) The patient-reported impact of scars measure: development and validation. Plast Reconstr Surg 125:1439–1449

    Article  CAS  PubMed  Google Scholar 

  13. Brown BC, Moss TP, McGrouther DA, Bayat A (2010) Skin scar preconceptions must be challenged: importance of self-perception in skin scarring. J Plast Reconstr Aesthet Surg 63:1022–1029

    Article  CAS  PubMed  Google Scholar 

  14. Conejo-Mir JS, Corbi R, Linares R (1998) Carbon dioxide laser ablation associated with interferon alfa-2b injection reduces the recurrence of keloids. J Am Acad Dermatol 39:1039–1040

    Article  CAS  PubMed  Google Scholar 

  15. Converse JM, Stallings JO (1972) Eradication of large auricular keloids by excision, skin grafting, and intradermal injection of triamcinolone acetonide solution. Case report. Plast Reconstr Surg 49:461–463

    Article  CAS  PubMed  Google Scholar 

  16. Cruz NI, Korchin L (1994) Inhibition of human keloid fibroblast growth by isotretinoin and triamcinolone acetonide in vitro. Ann Plast Surg 33:401–405

    Article  CAS  PubMed  Google Scholar 

  17. Darougheh A, Asilian A, Shariati F (2007) Intralesional triamcinolone alone or in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars. Clin Exp Dermatol 34:219–223

    Article  Google Scholar 

  18. Darzi MA, Chowdri NA, Kaul SK, Khan M (1992) Evaluation of various methods of treating keloids and hypertrophics scars: a 10-year follow-up study. Br J Plast Surg 45:374–379

    Article  CAS  PubMed  Google Scholar 

  19. Donkor P (2007) Head and neck keloid: treatment by core excision and delayed intralesional injection of steroid. J Oral Maxillofac Surg 65:1292–1296

    Article  PubMed  Google Scholar 

  20. Fitzpatrick RE (1999) Treatment of inflamed hypertrophic scars using intralesional 5FU. Dermatol Surg 25:224–232

    Article  CAS  PubMed  Google Scholar 

  21. Gangemi EN, Gregori D, Berchialla P et al (2008) Epidemiology and risk factors for pathologic scarring after burn wounds. Arch Facial Plast Surg 10:93–102

    Article  PubMed  Google Scholar 

  22. Hollywood KA, Maatje M, Shadi IT, Henderson A, McGrouther DA (2010) Phenotypic profiling of keloid scars using FT-IR microspectroscopy reveals a unique spectral signature. Arch Dermatol Res 302:705–715

    Article  PubMed  Google Scholar 

  23. Iqbal SA, Sidgwick GP, Bayat A (2012) Identification of fibrocytes from mesenchymal stem cells in keloid tissue: a potential source of abnormal fibroblasts in keloid scarring. Arch Dermatol Res 304:665–671

    Article  CAS  PubMed  Google Scholar 

  24. Jalali M, Bayat (2007) Current use of steroids in management of abnormal raised skin scars. Surgeon 5:175–180

    Article  CAS  PubMed  Google Scholar 

  25. Kill J (1977) Keloids treated with topical injections of triamcinolone acetonide (kenalog): immediate and long-term results. Scand J Plast Reconstr Surg 11:169–172

    Article  Google Scholar 

  26. Koc E, Arca E, Surucu B, Kurumlu Z (2008) An open, randomized, controlled, comparative study of the combined effect of intralesional triamcinolone acetonide and onion extract gel and intralesional triamcinolone acetonide alone in the treatment of hypertrophic scars and keloids. Dermatol Surg 34:1507–1514

    Article  CAS  PubMed  Google Scholar 

  27. Krusche T, Worret WI (1995) Mechanical properties of keloids in vivo during treatment with intralesional triamcinolone acetonide. Arch Dermatol Res 287:289–293

    Article  CAS  PubMed  Google Scholar 

  28. Larrabee WF, East CA, Jaffe HS, Stephensen C, Peterson KE (1990) Intralesional interferon gamma treatment for keloids and hypertrophic scars. Arch Otolaryngol Head Neck Surg 116:1159–1162

    Article  PubMed  Google Scholar 

  29. Layton AM, Yip J, Cunliffe WJ (1994) A comparison of intralesional triamcinolone and cryosurgery in the treatment of acne keloids. Br J Dermatol 130:498–501

    Article  CAS  PubMed  Google Scholar 

  30. Lee Y, Minn KW, Baek RM, Hong JJ (2001) A new surgical treatment of keloid: keloid core excision. Ann Plast Surg 46:135–140

    Article  CAS  PubMed  Google Scholar 

  31. Leventhal D, Furr M, Reiter D (2006) Treatment of keloids and hypertrophic scars. Arch Facial Plast Surg 8:362–368

    Article  PubMed  Google Scholar 

  32. Low SQ, Moy RL (1992) Scar war strategies. Target collagen. J Dermatol Surg Oncol 18:981–986

    Article  CAS  PubMed  Google Scholar 

  33. Manuskiatti W, Fitzpatrick RE (2002) Treatment response of keloidal and hypertrophic sternotomy scars. Comparison among intralesional corticosteroid, 5-fluorouracil, and 585 nm flashlamp-pumped pulsed dye laser treatments. Arch Dermatol 138:1149–1155

    Article  CAS  PubMed  Google Scholar 

  34. McCoy BJ, Diegelmann RF, Cohen IK (1980) In vitro inhibition of cell growth, collagen synthesis, and prolyl hydroxylase activity by triamcinolone acetonide. Proc Soc Exp Biol Med 163:216–222

    CAS  PubMed  Google Scholar 

  35. Mustoe TA, Cooter RD, Gold MH et al (2002) International clinical recommendations on scar management. Plast Reconstr Surg 110:560–571

    Article  PubMed  Google Scholar 

  36. Nedelec B, Shankowsky H, Tredget E (2000) Rating the resolving hypertrophic scar: comparison of the Vancouver Scar Scale and scar volume. J Burn Care Rehabil 21:205

    Article  CAS  PubMed  Google Scholar 

  37. Ragoowansi R, Cornes PGS, Glees JP, Powell BW, Moss AL (2001) Ear-lobe keloids: treatment by a protocol of surgical excision and immediate postoperative adjuvant radiotherapy. Br J Plast Surg 54:504–508

    Article  CAS  PubMed  Google Scholar 

  38. Rahban S, Garner W (2003) Fibroproliferative scars. Clin Plast Surg 30:77–89

    Article  PubMed  Google Scholar 

  39. Reed BR, Clark RA (1985) Cutaneous tissue repair: practical implications of current knowledge, II. J Am Acad Dermatol 13:919–941

    Article  CAS  PubMed  Google Scholar 

  40. Robles D, Moore E, Draznin M, Berg D (2007) Keloids: patho-physiology and management. Dermatol Online J 13:9

    PubMed  Google Scholar 

  41. Roques C, Teot L (2008) The use of corticosteroids to treat keloids: a review. Int J Low Extrem Wounds 7:137–145

    Article  PubMed  Google Scholar 

  42. Sadeghinia A, Sadeghinia S (2012) Comparison of the efficacy of intralesional triamcinolone acetonide and 5-fluorouracil tattooing for the treatment of keloids. Dermatol Surg 38:104–109

    Article  CAS  PubMed  Google Scholar 

  43. Salvarani C, Cantini F, Olivieri I, Barozzi L, Macchioni L, Boiardi L, Niccoli L, Padula A, Pulsatelli L, Meliconi R (2000) Corticosteroid injections in polymyalgia rheumatica: a double-blind, prospective, randomized, placebo controlled study. J Rheumatol 27:1470–1476

    CAS  PubMed  Google Scholar 

  44. Seifert O, Mrowietz U (2009) Keloid scarring: bench and bedside. Arch Dermatol Res 301:259–272

    Article  PubMed  Google Scholar 

  45. Shih B, Bayat A (2010) Genetics of keloid scarring. Arch Dermatol Res 302:319–339

    Article  CAS  PubMed  Google Scholar 

  46. Shih B, Bayat A (2012) Comparative genomic hybridisation analysis of keloid tissue in Caucasians suggests possible involvement of HLA-DRB5 in disease pathogenesis. Arch Dermatol Res 304:241–249

    Article  CAS  PubMed  Google Scholar 

  47. Singer AJ, Clark RA (1999) Cutaneous wound healing. N Engl J Med 341:738–746

    Article  CAS  PubMed  Google Scholar 

  48. Sund B (2000) New developments in wound care. PJB Publications, London

    Google Scholar 

  49. Syed F, Bayat A (2013) Superior effect of combination vs. single steroid therapy in keloid disease: a comparative in vitro analysis of glucocorticoids. Wound Repair Regen 21:88–102

    Article  PubMed  Google Scholar 

  50. van Zuijlen P, Angeles A, Kreis R, Bos KE, Middlekoop E (2002) Scar assessment tools: implications for current research. Plast Reconstr Surg 109:1108

    Article  PubMed  Google Scholar 

  51. Wu WS, Wang FS, Yang KD, Huang CC, Kuo YR (2006) Dexamethasone induction of keloid regression through effective suppression of VEGF expression and keloid fibroblast proliferation. J Invest Dermatol 126:1264–1271

    Article  CAS  PubMed  Google Scholar 

  52. Yosipovitch G, Widijanti Sugeng M, Goon A, Chan YH, Goh CL (2001) A comparison of the combined effect of cryotherapy and corticosteroid injections versus corticosteroids and cryotherapy alone on keloids: a controlled study. J Dermatol Treat 12:87–90

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ardeshir Bayat.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ud-Din, S., Bowring, A., Derbyshire, B. et al. Identification of steroid sensitive responders versus non-responders in the treatment of keloid disease. Arch Dermatol Res 305, 423–432 (2013). https://doi.org/10.1007/s00403-013-1328-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-013-1328-7

Keywords

Navigation